An Australian company is testing whether medicinal cannabis product could be used to treat medical conditions in family pets. After a successful trial of cannabis-based medicine to help treat conditions in dogs, CannPal is now expanding its testing to cats.
The company’s managing director Layton Mills, who was previously based in Canberra, said the products could be used to treat a range of illnesses.
“For dogs, we’ve been able to treat conditions like osteoarthritis and hip dysplaysia and skin health and other areas like epilepsy and behavioural issues,” Mr Mills said.
“When we talk about what can be treated, at the moment the sky is the limit as we’re learning more about the plant.
Medicinal cannabis for human consumption is already legal in Australia, but patients looking to use it have to go through several approval processes with the Therapeutic Goods Administration, federal and state governments.
Among the conditions treated in humans are epilepsy, multiple sclerosis, chronic pain and chemotherapy-induced nausea.